We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.

About CardioRisk

Canadian dyslipidemia guidelines application

CardioRisk Calculator™ simplifies cardiovascular risk stratification and is a Canadian dyslipidemia guidelines application.

CardioRisk Calculator™ provides:

-quick calculations on % LDL-C reductions

-concise drug dosage information

-clear snapshot of a patient's CV risk

-options to bring lipid levels to target

-easy identification of familial hypercholesterolemia

This application has been developed with the ultimate goal of educating physicians on the most recent Canadian dyslipidemia guidelines and guidelines for the diagnosis of familial hypercholesterolemia.

Programming support for the CardioRisk Calculator™ was provided through unrestricted grants to support the CardioRisk Clinic from the following (in alphabetical order):

Amgen Canada

Bayer Inc

Boehringer Ingelheim (Canada) Ltd

FH Canada

HLS Therapeutics

Janssen Inc

Novo Nordisk Canada

Sanofi Canada

What's New in the Latest Version 1.6.9

Last updated on Oct 7, 2023

- UPDATED FEATURE: 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults - expanded paragraph regarding statin-indicated conditions

Translation Loading...

Additional APP Information

Latest Version

Request CardioRisk Update 1.6.9

Uploaded by

Irina Paqsadze

Requires Android

Android 4.0.3+

Available on

Get CardioRisk on Google Play

Show More

CardioRisk Screenshots

Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.